Zeon Corporation · TSE:4205
Zeon — Investor Presentation (November 2024)
29 slides from Zeon's investor presentation, Nov 11, 2024
Slide 1: 高機能樹脂(COP&フィルム、C5モノマーバランス)事業説明会
SAS petits (COP&IT)bA. CSEJY—-NGYAZ) ZEON BREAD AREA 20244115118
Slide 2: 目次
目次 2 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 3: ©ZEON CORPORATION. All rights reserved.
3 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 4: 1. 高機能樹脂事業のビジネスモデル
1. 高機能樹脂事業のビジネスモデル 4 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 5: 2. COPの原料
2. COPの原料 5 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 6: 3. 生産数量の推移
3. 生産数量の推移 6 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 7: 4. 市場と成長性(まとめ)
4. 市場と成長性(まとめ) 7 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 8: 5. COPの構造と特徴
5. COPの構造と特徴 8 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 9: 6. COPの用途
6. COPの用途 9 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 10: 7. COP生産能力拡大の推移
7. COP生産能力拡大の推移 10 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 11: ©ZEON CORPORATION. All rights reserved.
11 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 12: 8-① 医療用途:COPの優位性
8-① 医療用途:COPの優位性 12 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 13: 8-① 医療用途におけるCOP採用の要因
8-① 医療用途におけるCOP採用の要因 13 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 14: 8-① 医療用途におけるCOP採用の要因
8-① 医療用途におけるCOP採用の要因 14 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 15: 8-① 医療用途におけるCOP採用の要因
8-① 医療用途におけるCOP採用の要因 15 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 16: 8-① 医療用途における市場成長
8-① 医療用途における市場成長 16 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 17: 8-② 半導体容器(ウエハー格納容器)の課題
8-② 半導体容器(ウエハー格納容器)の課題 17 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 18: 8-② ウエハー格納容器用途におけるCOP採用の要因
8-② ウエハー格納容器用途におけるCOP採用の要因 18 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 19: 8-③ COP樹脂販売実績
8-③ COP樹脂販売実績 19 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 20: ©ZEON CORPORATION. All rights reserved.
20 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 21: 9-① フィルム加工技術の強み
9-① フィルム加工技術の強み 21 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 22: 9-① フィルム加工技術の強み
9-① フィルム加工技術の強み 22 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 23: 9-② COPフィルムの特徴(位相差フィルムとしての機能)
9-② COPフィルムの特徴(位相差フィルムとしての機能) 23 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 24: 9-③ 位相差フィルムにおけるCOPの優位性
9-③ 位相差フィルムにおけるCOPの優位性 24 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 25: 9-④ COP光学フィルム(位相差フィルム)市場分析
9-④ COP光学フィルム(位相差フィルム)市場分析 25 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 26: ©ZEON CORPORATION. All rights reserved.
26 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 27: 1. C5モノマーバランスの現状
1. C5モノマーバランスの現状 27 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 28: 2. 改善計画の概要
2. 改善計画の概要 28 Any distribution, copying, or forwarding is strictly prohibited. ©ZEON CORPORATION. All rights reserved.
Slide 29: © ZEON CORPORATION. All rights reserved.
29 ©ZEON CORPORATION. All rights reserved.